Deleterious germline variants of BReast CAncer susceptibility genes BRCA1 and BRCA2 (BRCA) significantly increase the risk of developing “BRCA mutation”-related tumors, including breast, ovarian, pancreatic, and prostate cancer [1]. The gene discussed is BRCA2; the disease is Familial prostate cancer.